| Prevalence and management of mild hypogonadism: introduction. | |
| | |
MedLine Citation:
|
PMID: 12934043 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Although male hypogonadism can adversely affect the well-being of otherwise healthy men, physicians sometimes overlook it as a possible contributing factor to decreased libido, erectile dysfunction (ED), irritability, osteoporosis, and decreased muscle mass. However, hypogonadism is easily treated by testosterone replacement therapy, which may provide benefits such as mood improvement, increased bone density, and possibly reduced risk of type II diabetes. Articles in this supplement focus on populations that may benefit from testosterone replacement therapy (eg, men with type II diabetes, HIV, and ED). An overview of male 'andropause' is also provided. The authors discuss the surprisingly high prevalence of hypogonadism in certain patient populations and its impact on quality of life. Although testosterone has been used therapeutically for years, much remains to be learn about this hormone and its positive effects. |
| | |
Authors:
|
J S Tenover |
Related Documents
:
|
2625713 - Diagnostic value of ferritin measurements in patients with pleural effusions. 9288553 - Nephropathy in type ii diabetes. 11773523 - Reappraisal of the currently prevailing model of starch biosynthesis in photosynthetic ... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: International journal of impotence research Volume: 15 Suppl 4 ISSN: 0955-9930 ISO Abbreviation: Int. J. Impot. Res. Publication Date: 2003 Aug |
Date Detail:
|
Created Date: 2003-08-22 Completed Date: 2004-04-02 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 9007383 Medline TA: Int J Impot Res Country: England |
Other Details:
|
Languages: eng Pagination: S1-2 Citation Subset: IM |
Affiliation:
|
Wesley Woods Health Center, Atlanta, Georgia 30329, USA. jtenove@emory.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Erectile Dysfunction
/
etiology Hormone Replacement Therapy Humans Hypogonadism / complications, epidemiology*, therapy* Male Osteoporosis / etiology Testosterone / therapeutic use |
| Chemical | |
Reg. No./Substance:
|
58-22-0/Testosterone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The pathoanatomy of lateral ligamentous disruption in complex elbow instability.
Next Document: Declining testicular function in aging men.